Athira pharma announces upcoming presentations at the american academy of neurology (aan) 2023 annual meeting

Oral presentation to highlight additional clinical data from phase 2 act-ad trial of fosgonimeton in mild-to-moderate alzheimer's disease patients including improvements in measures of cognition and plasma biomarkers
ATHA Ratings Summary
ATHA Quant Ranking